These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 21311975

  • 1. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J.
    Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
    [Abstract] [Full Text] [Related]

  • 2. Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells.
    Liu A, Liu Y, Xu Z, Yu W, Wang H, Li C, Lin J.
    Cancer Sci; 2011 Jul; 102(7):1381-7. PubMed ID: 21435102
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 4. SD-1029 inhibits signal transducer and activator of transcription 3 nuclear translocation.
    Duan Z, Bradner JE, Greenberg E, Levine R, Foster R, Mahoney J, Seiden MV.
    Clin Cancer Res; 2006 Nov 15; 12(22):6844-52. PubMed ID: 17121906
    [Abstract] [Full Text] [Related]

  • 5. A novel obatoclax derivative, SC-2001, induces apoptosis in hepatocellular carcinoma cells through SHP-1-dependent STAT3 inactivation.
    Chen KF, Su JC, Liu CY, Huang JW, Chen KC, Chen WL, Tai WT, Shiau CW.
    Cancer Lett; 2012 Aug 01; 321(1):27-35. PubMed ID: 22465052
    [Abstract] [Full Text] [Related]

  • 6. Jak inhibitor induces S phase cell-cycle arrest and augments TRAIL-induced apoptosis in human hepatocellular carcinoma cells.
    Fuke H, Shiraki K, Sugimoto K, Tanaka J, Beppu T, Yoneda K, Yamamoto N, Ito K, Masuya M, Takei Y.
    Biochem Biophys Res Commun; 2007 Nov 23; 363(3):738-44. PubMed ID: 17904524
    [Abstract] [Full Text] [Related]

  • 7. XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells.
    Liu A, Liu Y, Jin Z, Hu Q, Lin L, Jou D, Yang J, Xu Z, Wang H, Li C, Lin J.
    PLoS One; 2012 Nov 23; 7(10):e46624. PubMed ID: 23056374
    [Abstract] [Full Text] [Related]

  • 8. CADPE suppresses cyclin D1 expression in hepatocellular carcinoma by blocking IL-6-induced STAT3 activation.
    Won C, Lee CS, Lee JK, Kim TJ, Lee KH, Yang YM, Kim YN, Ye SK, Chung MH.
    Anticancer Res; 2010 Feb 23; 30(2):481-8. PubMed ID: 20332458
    [Abstract] [Full Text] [Related]

  • 9. Diosgenin, a steroidal saponin, inhibits STAT3 signaling pathway leading to suppression of proliferation and chemosensitization of human hepatocellular carcinoma cells.
    Li F, Fernandez PP, Rajendran P, Hui KM, Sethi G.
    Cancer Lett; 2010 Jun 28; 292(2):197-207. PubMed ID: 20053498
    [Abstract] [Full Text] [Related]

  • 10. Identification of beta-escin as a novel inhibitor of signal transducer and activator of transcription 3/Janus-activated kinase 2 signaling pathway that suppresses proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Tan SM, Li F, Rajendran P, Kumar AP, Hui KM, Sethi G.
    J Pharmacol Exp Ther; 2010 Jul 28; 334(1):285-93. PubMed ID: 20378717
    [Abstract] [Full Text] [Related]

  • 11. 8-benzyl-4-oxo-8-azabicyclo[3.2.1]oct-2-ene-6,7-dicarboxylic acid (SD-1008), a novel janus kinase 2 inhibitor, increases chemotherapy sensitivity in human ovarian cancer cells.
    Duan Z, Bradner J, Greenberg E, Mazitschek R, Foster R, Mahoney J, Seiden MV.
    Mol Pharmacol; 2007 Nov 28; 72(5):1137-45. PubMed ID: 17675586
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors.
    Daka P, Liu A, Karunaratne C, Csatary E, Williams C, Xiao H, Lin J, Xu Z, Page RC, Wang H.
    Bioorg Med Chem; 2015 Mar 15; 23(6):1348-55. PubMed ID: 25698618
    [Abstract] [Full Text] [Related]

  • 13. Abrogation of constitutive STAT3 activity sensitizes human hepatoma cells to TRAIL-mediated apoptosis.
    Kusaba M, Nakao K, Goto T, Nishimura D, Kawashimo H, Shibata H, Motoyoshi Y, Taura N, Ichikawa T, Hamasaki K, Eguchi K.
    J Hepatol; 2007 Oct 15; 47(4):546-55. PubMed ID: 17602782
    [Abstract] [Full Text] [Related]

  • 14. Celecoxib inhibits interleukin-6/interleukin-6 receptor-induced JAK2/STAT3 phosphorylation in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Li H, Li C, Lin J.
    Cancer Prev Res (Phila); 2011 Aug 15; 4(8):1296-305. PubMed ID: 21490132
    [Abstract] [Full Text] [Related]

  • 15. Interferon-gamma-induced dephosphorylation of STAT3 and apoptosis are dependent on the mTOR pathway.
    Fang P, Hwa V, Rosenfeld RG.
    Exp Cell Res; 2006 May 01; 312(8):1229-39. PubMed ID: 16427044
    [Abstract] [Full Text] [Related]

  • 16. A sorafenib derivative and novel SHP-1 agonist, SC-59, acts synergistically with radiotherapy in hepatocellular carcinoma cells through inhibition of STAT3.
    Huang CY, Tai WT, Hsieh CY, Hsu WM, Lai YJ, Chen LJ, Shiau CW, Chen KF.
    Cancer Lett; 2014 Jul 28; 349(2):136-43. PubMed ID: 24735751
    [Abstract] [Full Text] [Related]

  • 17. Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.
    Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT.
    J Clin Pathol; 2007 Jun 28; 60(6):642-8. PubMed ID: 16901975
    [Abstract] [Full Text] [Related]

  • 18. Expression level of Bcl-XL critically affects sensitivity of hepatocellular carcinoma cells to LIGHT-enhanced and interferon-gamma-induced apoptosis.
    Li J, Shen F, Wu D, Wei LX, Wang YZ, Shi LH, Zou Y, Wu MC.
    Oncol Rep; 2007 May 28; 17(5):1067-75. PubMed ID: 17390046
    [Abstract] [Full Text] [Related]

  • 19. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J, Lin W, Cao Z, Liu L, Zhuang Q, Zhong X, Hong Z, Peng J.
    Oncol Rep; 2013 Sep 28; 30(3):1309-14. PubMed ID: 23828071
    [Abstract] [Full Text] [Related]

  • 20. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
    Sun X, Zhang J, Wang L, Tian Z.
    Cancer Lett; 2008 Apr 18; 262(2):201-13. PubMed ID: 18248786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.